Trial Profile
Open-Label Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2021
Price :
$35
*
At a glance
- Drugs Deselsulfavirine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Proof of concept
- Sponsors Viriom
- 06 Dec 2021 Primary endpoint modified. Number of treatment arms reduced to 5 from 7. Male healthy volunteers included instead of all genders.
- 06 Dec 2021 Status changed from recruiting to completed.
- 04 May 2020 Results of single and multiple ascending dose study published in the Viriom Media Release.